MSI phenotype and MMR alterations in familial and sporadic gastric cancer-Reference-Cited by-同舟云学术

MSI phenotype and MMR alterations in familial and sporadic gastric cancer

Published:2010-06-07 Issue:7 Volume:128 Page:1606-1613
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Leite Marina,Corso Giovanni,Sousa Sónia,Milanezi Fernanda,Afonso Luís P.,Henrique Rui,Soares José Manuel,Castedo Sérgio,Carneiro Fátima,Roviello Franco,Oliveira Carla,Seruca Raquel

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Cancer burden in the year 2000. The global picture;Parkin;Eur J Cancer,2001

2. Hereditary gastric cancer;Oliveira;Best Pract Res Clin Gastroenterol,2009

3. E-cadherin germline mutations in familial gastric cancer;Guilford;Nature,1998

4. Familial gastric cancer: overview and guidelines for management;Caldas;J Med Genet,1999

5. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression;Oliveira;Gastroenterology,2009

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of microsatellite instability in patients with resectable gastric cancer;Journal of Gastrointestinal Surgery;2024-08

2. Efficacy and safety of anti-programmed death-1 antibody-based combination therapy in advanced or metastatic gastric or gastroesophageal junction cancer in Chinese patients: A real-world study;Science Progress;2024-07

3. Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair;Gastric Cancer;2024-06-26

4. Microsatellite instability in gastric cancer: molecular features and clinical implications;Clinical Cancer Bulletin;2024-05-21

5. A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability;European Journal of Cancer;2024-05